FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063342775> ?p ?o ?g. }

• W2063342775 endingPage "159" @default.
• W2063342775 startingPage "156" @default.
• W2063342775 abstract "<h2>Abstract</h2><h3>Object</h3> To perform an exploratory study evaluating memantine for several common non-motor problems in Parkinson's disease. <h3>Methods</h3> We conducted a single center, double-blind, placebo controlled pilot trial of memantine, titrated to 20 mg/day, in PD subjects. Inclusion criteria were intentionally broad and included both fluctuating and non-fluctuating patients. After baseline assessments, subjects (<i>N</i> = 40) were randomized to drug and placebo groups. They received a battery of traditional and non-motor assessments. After a safety call (2 weeks after baseline) they returned for identical assessments at week 8. An 8-week open label extension was started if desired. <h3>Results</h3> Subject demographics (age 69.1 ± 7.8; 24 males), were similar in the drug and placebo groups. Four dropped from the study while on drug vs. none on placebo. Two of 36 remaining dropped out over the 8-week open label section. Of the 34 who completed the final open label visit, 24 elected to be prescribed memantine after the study. During the controlled trial, there was no significant change in UPDRS section I or II, Epworth sleepiness scale, fatigue severity scale, Hamilton depression scale, Conner adult inventory, PD Quality of Life-39, or clinical global impressions. UPDRS on motor scores tended to improved, <i>p</i> = 0.19. <h3>Conclusion</h3> Memantine was well tolerated in PD; however, specific measures of sleepiness, fatigue, depression, and attention did not significantly improve. The majority of subjects elected to stay on the drug after the open label extension suggesting some unassessed benefit." @default.
• W2063342775 created "2016-06-24" @default.
• W2063342775 creator A5011265007 @default.
• W2063342775 creator A5049973510 @default.
• W2063342775 creator A5059257496 @default.
• W2063342775 creator A5086726410 @default.
• W2063342775 date "2011-03-01" @default.
• W2063342775 modified "2023-10-16" @default.
• W2063342775 title "Memantine for non-motor features of Parkinson’s disease: A double-blind placebo controlled exploratory pilot trial" @default.
• W2063342775 cites W1965797477 @default.
• W2063342775 cites W1966245721 @default.
• W2063342775 cites W1984261359 @default.
• W2063342775 cites W1990915163 @default.
• W2063342775 cites W1991168471 @default.
• W2063342775 cites W1997411557 @default.
• W2063342775 cites W2002902382 @default.
• W2063342775 cites W2006611387 @default.
• W2063342775 cites W2040478347 @default.
• W2063342775 cites W2104165977 @default.
• W2063342775 cites W2110350185 @default.
• W2063342775 cites W2112914675 @default.
• W2063342775 cites W2129036744 @default.
• W2063342775 cites W2161593639 @default.
• W2063342775 cites W2163953162 @default.
• W2063342775 cites W2185080514 @default.
• W2063342775 cites W2419932231 @default.
• W2063342775 doi "https://doi.org/10.1016/j.parkreldis.2010.12.003" @default.
• W2063342775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21193343" @default.
• W2063342775 hasPublicationYear "2011" @default.
• W2063342775 type Work @default.
• W2063342775 sameAs 2063342775 @default.
• W2063342775 citedByCount "49" @default.
• W2063342775 countsByYear W20633427752012 @default.
• W2063342775 countsByYear W20633427752013 @default.
• W2063342775 countsByYear W20633427752014 @default.
• W2063342775 countsByYear W20633427752015 @default.
• W2063342775 countsByYear W20633427752016 @default.
• W2063342775 countsByYear W20633427752017 @default.
• W2063342775 countsByYear W20633427752018 @default.
• W2063342775 countsByYear W20633427752019 @default.
• W2063342775 countsByYear W20633427752020 @default.
• W2063342775 countsByYear W20633427752021 @default.
• W2063342775 countsByYear W20633427752022 @default.
• W2063342775 countsByYear W20633427752023 @default.
• W2063342775 crossrefType "journal-article" @default.
• W2063342775 hasAuthorship W2063342775A5011265007 @default.
• W2063342775 hasAuthorship W2063342775A5049973510 @default.
• W2063342775 hasAuthorship W2063342775A5059257496 @default.
• W2063342775 hasAuthorship W2063342775A5086726410 @default.
• W2063342775 hasConcept C126322002 @default.
• W2063342775 hasConcept C139719470 @default.
• W2063342775 hasConcept C142724271 @default.
• W2063342775 hasConcept C144024400 @default.
• W2063342775 hasConcept C149923435 @default.
• W2063342775 hasConcept C15744967 @default.
• W2063342775 hasConcept C159110408 @default.
• W2063342775 hasConcept C162324750 @default.
• W2063342775 hasConcept C168563851 @default.
• W2063342775 hasConcept C1862650 @default.
• W2063342775 hasConcept C204787440 @default.
• W2063342775 hasConcept C27081682 @default.
• W2063342775 hasConcept C2776867660 @default.
• W2063342775 hasConcept C2778205975 @default.
• W2063342775 hasConcept C2778664715 @default.
• W2063342775 hasConcept C2779134260 @default.
• W2063342775 hasConcept C2779483572 @default.
• W2063342775 hasConcept C2779484449 @default.
• W2063342775 hasConcept C2779951463 @default.
• W2063342775 hasConcept C2780084366 @default.
• W2063342775 hasConcept C2781326671 @default.
• W2063342775 hasConcept C535046627 @default.
• W2063342775 hasConcept C71924100 @default.
• W2063342775 hasConcept C99508421 @default.
• W2063342775 hasConceptScore W2063342775C126322002 @default.
• W2063342775 hasConceptScore W2063342775C139719470 @default.
• W2063342775 hasConceptScore W2063342775C142724271 @default.
• W2063342775 hasConceptScore W2063342775C144024400 @default.
• W2063342775 hasConceptScore W2063342775C149923435 @default.
• W2063342775 hasConceptScore W2063342775C15744967 @default.
• W2063342775 hasConceptScore W2063342775C159110408 @default.
• W2063342775 hasConceptScore W2063342775C162324750 @default.
• W2063342775 hasConceptScore W2063342775C168563851 @default.
• W2063342775 hasConceptScore W2063342775C1862650 @default.
• W2063342775 hasConceptScore W2063342775C204787440 @default.
• W2063342775 hasConceptScore W2063342775C27081682 @default.
• W2063342775 hasConceptScore W2063342775C2776867660 @default.
• W2063342775 hasConceptScore W2063342775C2778205975 @default.
• W2063342775 hasConceptScore W2063342775C2778664715 @default.
• W2063342775 hasConceptScore W2063342775C2779134260 @default.
• W2063342775 hasConceptScore W2063342775C2779483572 @default.
• W2063342775 hasConceptScore W2063342775C2779484449 @default.
• W2063342775 hasConceptScore W2063342775C2779951463 @default.
• W2063342775 hasConceptScore W2063342775C2780084366 @default.
• W2063342775 hasConceptScore W2063342775C2781326671 @default.
• W2063342775 hasConceptScore W2063342775C535046627 @default.
• W2063342775 hasConceptScore W2063342775C71924100 @default.
• W2063342775 hasConceptScore W2063342775C99508421 @default.
• W2063342775 hasIssue "3" @default.

• next